Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 50 member A (FAM50A) is a nuclear basic protein encoded on the X chromosome (Xq28) that contains a nuclear localization signal and can function as a DNA-binding protein or putative transcription factor[2][5]. FAM50A is an essential component of the spliceosome C complex and plays a role in pre-mRNA splicing, with particular relevance to neural development and craniofacial patterning as evidenced by knockout animal models[1]. Pathogenic mutations in FAM50A are the genetic cause of Armfield X-linked intellectual disability (XLID) syndrome, characterized by intellectual disability, developmental delay, distinctive facial features, and ophthalmological findings[1][3]. In cancer, FAM50A appears to act as a pro-oncogenic factor, promoting cell proliferation, migration, invasion, epithelial–mesenchymal transition, and resistance to apoptosis in hepatocellular carcinoma and possibly other tumors[2]. High FAM50A expression in HCC is associated with poor prognosis, enhanced immune cell infiltration, and resistance to certain therapies (e.g., reduced lenvatinib sensitivity), making it a potential biomarker and therapeutic target in oncology[2]. There is ongoing research into FAM50A's precise molecular roles, but it is currently not classified under traditional target classes such as enzyme, transporter, or receptor; rather, it is linked to RNA processing, transcriptional regulation, and tumor biology[1][2][5].
Alteration of mRNA splicing and processing\nRegulation of epithelial–mesenchymal transition and cell proliferation in cancer[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 50 member A (FAM50A).